Navigation Links
Melanomas on Scalp and Neck More Deadly
Date:4/21/2008

ose areas at the molecular level and to see if there are differences. I'm interested in identifying the mutations that drive malignancy," Thomas said.

The patients included in study were non-Hispanic white adults in nine states who were first diagnosed with invasive melanoma between 1992 and 2003. Patients with scalp-neck melanomas were more likely to be male and were an average age of 59 years, compared to 55 years for those with other melanomas.

Scalp-neck melanomas were thicker (0.8 millimeters) than other melanomas (0.6 millimeters) and more likely to be ulcerated. The study also found that lymph node involvement was more common in cases of scalp-neck melanomas.

More information

The American Academy of Family Physicians has more about melanoma.



-- Robert Preidt



SOURCE: University of North Carolina at Chapel Hill, news release, April 21, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Melanomas may appear noticeably different than other moles
2. Melanomas Present Unique Appearance
3. Drug Proves Effective in Slowing Melanomas
4. Scientists Probe Sepsis Deadly Secrets
5. HIV denialists spread misinformation online -- consequences could be deadly; and more
6. Greeks get space-based help in wake of deadly fires
7. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
8. Drug combination might offer hope for patients deadly brain tumors
9. MARCOR Responds to Deadly MRSA Outbreak
10. Common virus may help doctors treat deadly brain tumors
11. A new key to detecting deadly aortic aneurysms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...to Historic Low as Pharma Companies Face ...ONDON, July 24 /PRNewswire/ -- The Scientific busi...bility of the newly published CMR,International 20...eference,and business planning tool for decision m...siness strategy, marketing planning and corporate,...
(Date:7/23/2008)...ke Forest University Baptist Medical Center demons...fying patients who are having a heart attack, even..., The study used data from a registry called i*tr...oms who were admitted to emergency departments (ED...indings were released today in the Emergency Medi...
(Date:7/23/2008)... July 23 /PRNewswire-FirstCall/ - Cardiome Pharma ... it has entered into an,agreement with CR Intrinsi...CR Intrinsic Investors, LLC, an affiliate of S.A.C...rtible preferred shares for gross proceeds of,US$2...for general corporate,purposes, costs associated w...
(Date:7/23/2008)...ll/ -- The Hanover Insurance Group,a leading supe...nounced it,is prepared to respond to claims result...h southern Texas today., (Logo: http://www.newsc...re deeply concerned about individuals and business...t of The Hanover,s Central Region. "Our,staff is s...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...s organized crime that is on the brink of milking ... by foreigners to avail free medical treatment, ac...y. These phony deals have cost a mammoth $90 milli...ports.// The agency has reported a case of a Vic...
...cturers based at Washington have been blamed for n... effects of chromium exposure to the Government. /...eported. A paper submitted by George Washington ...ted the incomplete data published with respect to ...
...GELES - Doctors have revealed that the 7-month-old...ng heart transplant has shown good signs of recove...inues to fight for life.// Nick Draper was fitted...ration last week at the University of California, ...
...S. Environmental Protection Agency's National Air ... industrialized areas where air pollution is a way... The EPA, which// estimated the risk of developing...d result if a million people in a particular area ...
Other Medicine News:
(Date:7/22/2008)... and pegylated enzyme produces significantly en... - Pegylated enzyme well tolerated ...alozyme Therapeutics,Inc. (Nasdaq: HALO ), a bio...ing products targeting the extracellular matrix, t...inical animal efficacy data,for its pegylated-rHuP...
(Date:7/22/2008)...Approach of LASH (Laser Assisted Scar Healing)... MARSEILLES, France, July 22 /- Ekkyo...dicine company, which develops first-in-class,lase...tion, announced today,the publication of a scienti...orting the results of a pilot study on cutaneous s...
(Date:7/21/2008)... 2008 conferences, GAITHERSBURG, Md., July 21 /PR... company developing gene therapies for HIV and gen...6 Phase I and Phase II,clinical trials for the med...s an investigational gene therapy for the treatmen...rsday, July 24, 2008 at 11 a.m. EDT. The,presentat...
(Date:7/21/2008)...impedance spectroscopy (BIS) is,more accurate and ...ent of,lymphedema in breast cancer patients, accor...Journal of Clinical Oncology (2008; Vol. 26, Issue...t Cancer: Incidence, Risk Factors, and,Effect on U... Hayes, PhD.,and colleagues from Queensland Unive...
Breaking Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3Into the wild 3447 1Life but not as we know it 3F 3443 1Life but not as we know it 3F 3443 2X rays often repeated for patients in developing countries 20385 1X rays often repeated for patients in developing countries 20385 2X rays often repeated for patients in developing countries 20385 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 1Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 2Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 4
...YTOWN, N.Y., June 15, 2007 /PRNewswire-FirstCall/ ... of scientific studies that,(1) demonstrate that A...ple types of human tumors in animal models, (2) re...cts, and (3) show that,MPC-6827 is not affected by...drug resistance. The study results appear in the J...
...HIGH WYCOMBE, England, June 18, 2007 /PRNewswire/ ...g how a new flu vaccine has the,potential to prote...demic and annual, was presented today by PepTcell,...VI (Options) Conference, in,Toronto, Canada. , The...the,European Journal of Immunology, showed how mic...
Other Medicine Technology:New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
...DA Closure Device has been developed for the trans...troduced through standard venous sheaths (10-14F) ...he percutaneous closure of persistent ductal shunt...,An integral locking delivery and retrieval m...
Swanson Finger Pins are stainless steel and available in one length and three diameters.
Round Bevel-Point Hook Pin available in 2.3mm, 3.1mm, 4.7mm, and 6.3mm sizes.
Suture Passer is available with a 3/64 in. (.50 mm) hole in each end. Material: DePuy certified stainless steel. (sold in packs of six each)
Medicine Products: